May 2012 Issue of MMM
MAY 2012 issue
Like it or not, you have an obligation to communicate with your stakeholders
When big pharma looks in the mirror, what does it see? A body beset by old, expiring brands and not enough energetic, youthful ones to ...
Following industry's CME cutback, dinner meetings and other kinds of peer-to-peer interaction are grabbing more of its meeting spend. How much more, and is this ...
Getting too enamored of products can lead to losing sight of customer needs. Fred Kinch on how to avoid being blinded by product devotion
This year's judges for the MM&M Awards once again represent the cream of the industry's leaders and thinkers. But this year, there are twice as ...
Tim Hayes, President, Bayer HealthCare Consumer Care North America
When it comes to multicultural marketing, a patient-centered focus is still an evolving, nascent notion in pharma
Not enough attention has been paid congratulating Merck for its shingles homerun, Zostavax
FDA issues may deter drugmakers from engaging in social media, but that's no excuse to ignore what audiences are saying on these platforms
The drug industry is struggling with more than expiring patents and shrinking sales forces, Millennium Pharmaceuticals CEO Deborah Dunsire told industry watchers in March. Rather, ...
Women are simultaneously given more drugs than men and undertreated, according to a study by Medco and the Society of Women's Health Research.
News on Daiichi Sankyo, Delta Point, Doctor Insights and Corcept Therapeutics
Med Ed Report
Could an online quiz be the future of continuing medical education?
Accredited medical education and communications firm NACCME acquired CME LLC, which operates the US Psychiatric & Mental Health Congress.
A survey of 971 physicians showed that, while most said they would prefer to take CME training online, only 6.4% actually participate in virtual training ...
News on Sunshine Act, Viscira, CBI, Stanford Medical School, Cutting Edge Information
The diabetes crisis and the amount of research connected to the disease is prompting publisher Elsevier to increase the heft and frequency of its Journal ...
Science and media publisher Springer is unrolling a new platform for its corporate clients called Springer R&D.
News on Thieme, MedPage Today and Nature Publishing Group
Media data show pharma spent more for ads in magazines (+1%) and newspapers (+3%) last year, along with journals (+6%), but less in TV, outdoor ...
Sermo has named former Revolution Health president Tim Davenport CEO.
GlaxoSmithKline is souping up its social-media monitoring with a strategy it says will create processes standard enough to streamline communications, but flexible enough to meet ...
News on HealthiNation, thebump.com, Medscape Mobile, Ignite Health
Boehringer Ingelheim is handing over the keys to its public health initiative, Drive4COPD, to the non-profit COPD Foundation.
Numbers, not patients, start in the AndroGel campaign
Everyday Health last month launched a YouTube channel.
Genentech is thinking outside the traditional focus group to better understand patients which, in turn, is helping address adherence and brand preference.
Biopharma consultancy Campbell Alliance launched a market research and analytics group, one that could pose a threat to traditional MR firms.
Omnicom's CAHG is partnering with sibling network TBWA/WorldHealth.
Medical Advertising Hall of Fame members met with prospective recruits at a breakfast roundtable
LLNS named Steve Hamburg chief creative officer.
News on Harrison and Star, Paul Werth Associates, Concentric Pharma, Chandler Chicco, Rosetta, CHG and Vox Medica
There are claims that a politically independent FDA belongs in "a world that doesn't exist any more"
FDA drugs director Janet Woodcock told the House Energy and Commerce Committee in March that Congress should not change the standards for determining a therapy's ...
A Union of Concerned Scientists survey of 997 FDA scientists suggests that agency leaders are helping to boost scientific integrity but still are beset by ...
Don't think that client marketers and their procurement colleagues don't have the "lists"
Five campaigns that do a great job of connecting with pain sufferers in unique and creative ways.
At Work With
John Curbishley, EVP, Business and Product Development, AccentHealth
Andrew Hurd, President and CEO, Epocrates
Manufacturer, market research and agency hires and promotions
Name That Brand
Improved patient outcomes must be a stated, and measured, goal of all players in the pharma industry
Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.